<ENAMEX TYPE="ORGANIZATION">EG G Inc</ENAMEX> said it acquired <ENAMEX TYPE="ORGANIZATION">Laboratorium Prof Dr Berthold</ENAMEX> a German maker of scientific instruments Terms weren t disclosed The <ENAMEX TYPE="LOCATION">Wellesley Mass</ENAMEX> maker of scientific instruments and electronic parts said <ENAMEX TYPE="ORGANIZATION">Berthold</ENAMEX> expects 1989 sales of more than 100 million Deutsche marks 54 5 million and employs about 400 people <ENAMEX TYPE="ORGANIZATION">Berthold</ENAMEX> is based in <ENAMEX TYPE="LOCATION">Wildbad West Germany</ENAMEX> and also has operations in <ENAMEX TYPE="LOCATION">Belgium John M Kucharski EG G</ENAMEX> s chairman and chief executive said the acquisition will extend EG G s core technologies strengthen its position in the European Economic Community and assure a strength and presence in the Eastern European market He said it especially will strengthen the company s efforts in the rapidly growing field of bio analytical instrumentation and in applied nuclear physics Separately EG G said it sold most of its <ENAMEX TYPE="ORGANIZATION">Mason Research Institute</ENAMEX> subsidiary to <ENAMEX TYPE="ORGANIZATION">Transgenic</ENAMEX> Sciences <ENAMEX TYPE="ORGANIZATION">Inc</ENAMEX> a closely held biotechnology company based in <ENAMEX TYPE="LOCATION">Worcester Mass</ENAMEX> The sale for 7 million in cash and securities will leave EG G with a 12 stake in <ENAMEX TYPE="ORGANIZATION">Transgenic</ENAMEX> executives said <ENAMEX TYPE="PERSON">Mason</ENAMEX> is the largest toxicology lab in <ENAMEX TYPE="LOCATION">New England</ENAMEX> with annual revenue of 8 million and 140 employees <ENAMEX TYPE="PERSON">Mason</ENAMEX> serves commercial and government customers including the <ENAMEX TYPE="ORGANIZATION">National</ENAMEX> Institutes of Health The combined companies will become profitable by <ENAMEX TYPE="LOCATION">January</ENAMEX> 1990 said <ENAMEX TYPE="PERSON">James P Sherblom Transgenic</ENAMEX> s chairman and chief executive officer